Interesting the HC posters on the KZA JG resignation thread...

Interesting the HC posters on the KZA JG resignation thread generally say he was good at the science but lacked a bit commercially and botched a few cap raises. Also there was the suggestion he didn’t like KZA shareholders voting down his option grab at the last AGM.

I realise small cap ASX biotech CEOs that are available to be employed are not not milling about in abundance, but hope we haven’t hired in our current strengths and weaknesses likeness.

CG moving to an exec role is promising. Probably was already putting in the exec time without pay. Still a small board that she controls.

Would be nice if she added to her $10k shareholding.